NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Superinvestors holding NXTC, Q2 2026
No superinvestor reported holding NXTC in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of NXTC each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)